Developing an OBL: Key Considerations Before Spending a Dime Or Too Much Time
- PMID: 39025611
- DOI: 10.1016/j.tvir.2024.100950
Developing an OBL: Key Considerations Before Spending a Dime Or Too Much Time
Abstract
The office-based laboratory (OBL) industry has proliferated over the past decade as surgical cases have increasingly migrated from inpatient to outpatient surgical settings, including OBLs, ambulatory surgery centers and infusion centers. Although many physicians and patients prefer to provide and receive care in an OBL setting because it provides a high quality, lower cost and convenient alternative to receiving care in a hospital, the OBL industry is nonetheless under attack on a variety of fronts. Governmental and commercial payor reimbursement for OBL procedures has declined substantially over time, and there have been lawsuits, governmental investigations and news articles that have been critical of care provided in OBLs. These issues have generated headwinds for this young but growing industry. It is therefore important for physicians and investors alike interested in developing an OBL to be aware of the complex landscape of laws and regulations that apply to OBLs. This article provides an overview of key legal, corporate, tax, financial and structural considerations for operators to be aware of before opening an OBL.
Keywords: OBL; Office-based laboratory; develop; endovascular; physician practice; vascular center.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Neither author has any actual or potential conflict of interest, including any financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, the information contained in this article.
Similar articles
-
Initial financial impact of office-based laboratories on Medicare payments for percutaneous interventions for peripheral artery disease.J Vasc Surg. 2020 Aug;72(2):686-691.e1. doi: 10.1016/j.jvs.2019.09.064. Epub 2020 Jan 20. J Vasc Surg. 2020. PMID: 31973948
-
Exploring the rapid expansion of office-based laboratories and peripheral vascular interventions across the United States.J Vasc Surg. 2021 Sep;74(3):997-1005.e1. doi: 10.1016/j.jvs.2021.01.061. Epub 2021 Feb 19. J Vasc Surg. 2021. PMID: 33617980 Free PMC article.
-
Budget Impact of Shifting the Treatment Setting of Unresectable Liver Metastases Associated with Primary Colorectal Cancer Using Y-90 Resin Microspheres from the Outpatient Hospital to the Office-Based Laboratory.Clinicoecon Outcomes Res. 2025 May 8;17:387-392. doi: 10.2147/CEOR.S492369. eCollection 2025. Clinicoecon Outcomes Res. 2025. PMID: 40357429 Free PMC article.
-
Physician refer thyself: is Stark II, phase III the final voyage?Pain Physician. 2007 Nov;10(6):725-41. Pain Physician. 2007. PMID: 17987094 Review.
-
Ambulatory surgery centers and interventional techniques: a look at long-term survival.Pain Physician. 2011 Mar-Apr;14(2):E177-215. Pain Physician. 2011. PMID: 21412380 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous